Heart Medical-B (06609.HK) has reported a profit, with an expected net profit attributable to shareholders of not less than 40 million yuan in the medium term, a significant turnaround from a loss to a profit year-on-year.

Zhixin Finance and Economics APP News, Xinwei Medical-B (06609.HK) announced that the group is expected to achieve a net profit attributable to shareholders of not less than RMB 40 million for the six months ending June 30, 2025, compared to a net loss attributable to shareholders of approximately RMB 5.1 million for the six months ending June 30, 2024. The expected profit and improvement in performance is mainly due to the growth of the group's business, resulting in an increase in revenue compared to the corresponding period and a decrease in the overall expense ratio of the group.